Review: taking Glyburide and Levemir together


Summary

Drug interactions are reported among people who take Glyburide and Levemir together. This review analyzes the effectiveness and drug interactions between Glyburide and Levemir. It is created by eHealthMe based on reports of 104 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Glyburide

Glyburide has active ingredients of glyburide. It is often used in diabetes. (latest outcomes from Glyburide 30,818 users)

Levemir

Levemir has active ingredients of insulin detemir. It is often used in type 2 diabetes. (latest outcomes from Levemir 5,101 users)

On Sep, 21, 2016

104 people who take Glyburide, Levemir are studied.


Number of reports submitted per year:

Glyburide and Levemir drug interactions.

Most common drug interactions over time *:

1 - 6 months:
  • bladder cancer
  • transitional cell carcinoma
6 - 12 months:
  • bladder cancer
1 - 2 years:
  • bladder cancer
  • death
  • bladder transitional cell carcinoma
  • cardiac failure congestive
  • renal cancer
2 - 5 years:
  • bladder cancer recurrent
  • bladder cancer stage iii
  • bladder transitional cell carcinoma
  • microcytic anaemia
  • myocardial infarction
  • upper gastrointestinal haemorrhage
  • bladder cancer
5 - 10 years:
  • bladder cancer
  • bladder cancer recurrent
  • bladder transitional cell carcinoma
  • cardiac failure congestive
  • chronic obstructive pulmonary disease
  • death
  • hypoglycaemia
  • hypoglycaemic unconsciousness
10+ years:
  • bladder cancer
not specified:
  • bladder cancer
  • blood glucose increased
  • bladder transitional cell carcinoma
  • nausea
  • dyspnoea
  • hypoglycaemia
  • blood glucose decreased
  • dehydration
  • urinary tract infection
  • fatigue

Most common drug interactions by gender *:

female:
  • blood glucose increased
  • dyspnoea
  • nausea
  • urinary tract infection
  • general physical health deterioration
  • insomnia
  • pericardial haemorrhage
  • anxiety
  • migraine
  • oedema peripheral
male:
  • blood glucose increased
  • hypoglycaemia
  • atrioventricular block first degree
  • syncope
  • urinary incontinence
  • blood glucose decreased
  • dehydration
  • fatigue
  • metastases to liver
  • myocardial infarction

Most common drug interactions by age *:

40-49:
  • accidental overdose
  • blood glucose increased
  • dehydration
  • diabetic ketoacidosis
  • diarrhoea
  • fibrocystic breast disease
  • nervousness
  • somnolence
  • suicidal ideation
  • visual impairment
50-59:
  • dyspnoea
  • general physical health deterioration
  • pericardial haemorrhage
  • anxiety
  • migraine
  • nausea
  • blood glucose increased
  • anaemia
  • anaemia postoperative
  • angina unstable
60+:
  • blood glucose increased
  • hypoglycaemia
  • blood glucose decreased
  • dehydration
  • fatigue
  • nausea
  • weight decreased
  • atrioventricular block first degree
  • syncope
  • urinary incontinence

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Glyburide and Levemir?

You may be interested in these reviews

More reviews for: Glyburide, Levemir

On eHealthMe, Glyburide (glyburide) is often used to treat diabetes. Levemir (insulin detemir) is often used to treat type 2 diabetes. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.